2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.7 | chromodomain helicase DNA binding protein 1 |
Pml
|
ENSMUSG00000036986.10 | promyelocytic leukemia |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Chd1 | mm10_v2_chr17_+_15704963_15704994 | -0.41 | 1.8e-01 | Click! |
Pml | mm10_v2_chr9_-_58249702_58249791 | 0.21 | 5.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_71963713 | 5.61 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr11_+_120530688 | 5.21 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr17_+_8801742 | 4.57 |
ENSMUST00000089085.2
|
Pde10a
|
phosphodiesterase 10A |
chr4_+_137277489 | 4.54 |
ENSMUST00000045747.4
|
Wnt4
|
wingless-related MMTV integration site 4 |
chr15_+_87625214 | 4.47 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chr12_-_84698769 | 4.42 |
ENSMUST00000095550.2
|
Syndig1l
|
synapse differentiation inducing 1 like |
chr11_-_119086221 | 4.38 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr2_+_130295148 | 4.36 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr13_+_48968287 | 4.05 |
ENSMUST00000180775.1
|
Fam120aos
|
family with sequence similarity 120A opposite strand |
chr5_+_30588078 | 4.05 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr11_+_61022560 | 3.94 |
ENSMUST00000089184.4
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chrX_+_69360294 | 3.94 |
ENSMUST00000033532.6
|
Aff2
|
AF4/FMR2 family, member 2 |
chr5_+_141241490 | 3.93 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr9_+_114978507 | 3.55 |
ENSMUST00000183104.1
|
Osbpl10
|
oxysterol binding protein-like 10 |
chr15_-_76521902 | 3.44 |
ENSMUST00000164703.1
ENSMUST00000096365.3 |
Scrt1
|
scratch homolog 1, zinc finger protein (Drosophila) |
chr19_-_10457447 | 3.24 |
ENSMUST00000171400.2
|
Lrrc10b
|
leucine rich repeat containing 10B |
chrX_-_7574120 | 3.22 |
ENSMUST00000045924.7
ENSMUST00000115742.2 ENSMUST00000150787.1 |
Ppp1r3f
|
protein phosphatase 1, regulatory (inhibitor) subunit 3F |
chr11_-_107794557 | 3.19 |
ENSMUST00000021066.3
|
Cacng4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr18_+_74442500 | 3.06 |
ENSMUST00000074157.6
|
Myo5b
|
myosin VB |
chr1_+_167001417 | 3.04 |
ENSMUST00000165874.1
|
Fam78b
|
family with sequence similarity 78, member B |
chr5_+_129941949 | 3.02 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr11_-_69369377 | 3.00 |
ENSMUST00000092971.6
ENSMUST00000108661.1 |
Chd3
|
chromodomain helicase DNA binding protein 3 |
chr12_-_104865076 | 2.84 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr3_-_8667033 | 2.81 |
ENSMUST00000042412.3
|
Hey1
|
hairy/enhancer-of-split related with YRPW motif 1 |
chr18_+_74442551 | 2.67 |
ENSMUST00000121875.1
|
Myo5b
|
myosin VB |
chr4_+_62965560 | 2.66 |
ENSMUST00000030043.6
ENSMUST00000107415.1 ENSMUST00000064814.5 |
Zfp618
|
zinc finger protein 618 |
chrX_+_94724569 | 2.62 |
ENSMUST00000101388.2
|
Zxdb
|
zinc finger, X-linked, duplicated B |
chr6_-_72789240 | 2.61 |
ENSMUST00000069536.5
|
Tcf7l1
|
transcription factor 7 like 1 (T cell specific, HMG box) |
chr7_+_49974864 | 2.60 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chr13_+_72628802 | 2.59 |
ENSMUST00000074372.4
|
Irx2
|
Iroquois related homeobox 2 (Drosophila) |
chr6_+_107529717 | 2.59 |
ENSMUST00000049285.8
|
Lrrn1
|
leucine rich repeat protein 1, neuronal |
chr1_+_167001457 | 2.58 |
ENSMUST00000126198.1
|
Fam78b
|
family with sequence similarity 78, member B |
chr3_-_90465858 | 2.58 |
ENSMUST00000029540.6
|
Npr1
|
natriuretic peptide receptor 1 |
chr5_+_138995038 | 2.55 |
ENSMUST00000100518.2
|
6330403L08Rik
|
RIKEN cDNA 6330403L08 gene |
chr4_-_139092958 | 2.51 |
ENSMUST00000042844.6
|
Nbl1
|
neuroblastoma, suppression of tumorigenicity 1 |
chr5_-_100159261 | 2.48 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chrX_+_170009659 | 2.47 |
ENSMUST00000179760.1
|
Gm21887
|
predicted gene, 21887 |
chr17_+_69969217 | 2.46 |
ENSMUST00000060072.5
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr12_-_79007276 | 2.46 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chrX_+_6047453 | 2.43 |
ENSMUST00000103007.3
|
Nudt11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr4_-_118291340 | 2.41 |
ENSMUST00000049074.6
|
Ptprf
|
protein tyrosine phosphatase, receptor type, F |
chr12_+_108334341 | 2.39 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr8_+_84415348 | 2.36 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr15_-_75747922 | 2.32 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chrX_-_135009185 | 2.32 |
ENSMUST00000113185.2
ENSMUST00000064659.5 |
Zmat1
|
zinc finger, matrin type 1 |
chr17_+_69969387 | 2.29 |
ENSMUST00000146730.1
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr4_+_138454305 | 2.28 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr5_+_34660361 | 2.27 |
ENSMUST00000074651.4
ENSMUST00000001112.7 |
Grk4
|
G protein-coupled receptor kinase 4 |
chr17_-_63499983 | 2.27 |
ENSMUST00000024761.6
|
Fbxl17
|
F-box and leucine-rich repeat protein 17 |
chr6_-_124769548 | 2.27 |
ENSMUST00000149652.1
ENSMUST00000112476.1 ENSMUST00000004378.8 |
Eno2
|
enolase 2, gamma neuronal |
chr3_-_57847478 | 2.26 |
ENSMUST00000120289.1
ENSMUST00000066882.8 |
Pfn2
|
profilin 2 |
chr5_-_22344690 | 2.26 |
ENSMUST00000062372.7
ENSMUST00000161356.1 |
Reln
|
reelin |
chr16_-_18586959 | 2.24 |
ENSMUST00000009241.5
|
Tbx1
|
T-box 1 |
chr8_+_76899772 | 2.24 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr10_+_82985473 | 2.23 |
ENSMUST00000040110.7
|
Chst11
|
carbohydrate sulfotransferase 11 |
chr6_-_100287441 | 2.21 |
ENSMUST00000101118.2
|
Rybp
|
RING1 and YY1 binding protein |
chr4_-_3938354 | 2.19 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr7_+_49975228 | 2.19 |
ENSMUST00000107603.1
|
Nell1
|
NEL-like 1 |
chr13_-_48870885 | 2.17 |
ENSMUST00000035540.7
|
Phf2
|
PHD finger protein 2 |
chr13_-_43480973 | 2.14 |
ENSMUST00000144326.2
|
Ranbp9
|
RAN binding protein 9 |
chr6_-_120493807 | 2.13 |
ENSMUST00000178687.1
|
Cecr6
|
cat eye syndrome chromosome region, candidate 6 |
chr17_-_67354459 | 2.11 |
ENSMUST00000037974.8
|
Ptprm
|
protein tyrosine phosphatase, receptor type, M |
chr16_-_22163299 | 2.10 |
ENSMUST00000100052.4
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr5_+_117357274 | 2.09 |
ENSMUST00000031309.9
|
Wsb2
|
WD repeat and SOCS box-containing 2 |
chr2_-_153529941 | 2.09 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr6_+_86526271 | 2.09 |
ENSMUST00000180896.1
|
1600020E01Rik
|
RIKEN cDNA 1600020E01 gene |
chr6_-_145250177 | 2.09 |
ENSMUST00000111710.1
ENSMUST00000155145.1 ENSMUST00000032399.5 |
Kras
|
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
chr5_+_137288273 | 2.09 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr5_-_138996087 | 2.09 |
ENSMUST00000110897.1
|
Pdgfa
|
platelet derived growth factor, alpha |
chr1_-_84696182 | 2.08 |
ENSMUST00000049126.6
|
Dner
|
delta/notch-like EGF-related receptor |
chr6_-_72788952 | 2.07 |
ENSMUST00000114053.2
|
Tcf7l1
|
transcription factor 7 like 1 (T cell specific, HMG box) |
chr19_+_3851972 | 2.07 |
ENSMUST00000025760.6
|
Chka
|
choline kinase alpha |
chr7_-_16614937 | 2.06 |
ENSMUST00000171937.1
ENSMUST00000075845.4 |
Grlf1
|
glucocorticoid receptor DNA binding factor 1 |
chr11_+_45980309 | 2.04 |
ENSMUST00000049038.3
|
Sox30
|
SRY-box containing gene 30 |
chr8_-_90348343 | 2.02 |
ENSMUST00000109621.3
|
Tox3
|
TOX high mobility group box family member 3 |
chr2_-_34372004 | 2.01 |
ENSMUST00000113132.2
ENSMUST00000040638.8 |
Pbx3
|
pre B cell leukemia homeobox 3 |
chr8_-_70353243 | 2.00 |
ENSMUST00000075666.6
|
Upf1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr1_-_134235420 | 2.00 |
ENSMUST00000038191.6
ENSMUST00000086465.4 |
Adora1
|
adenosine A1 receptor |
chr11_-_94474088 | 1.98 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr17_-_24689901 | 1.98 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr2_+_70562854 | 1.97 |
ENSMUST00000130998.1
|
Gad1
|
glutamate decarboxylase 1 |
chr17_+_24488773 | 1.97 |
ENSMUST00000024958.7
|
Caskin1
|
CASK interacting protein 1 |
chr14_+_14703025 | 1.95 |
ENSMUST00000057015.6
|
Slc4a7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
chrX_-_155623325 | 1.95 |
ENSMUST00000038665.5
|
Ptchd1
|
patched domain containing 1 |
chr2_-_130906338 | 1.90 |
ENSMUST00000146975.1
|
4930402H24Rik
|
RIKEN cDNA 4930402H24 gene |
chr4_-_114908892 | 1.90 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr5_+_34369909 | 1.90 |
ENSMUST00000180376.1
|
Fam193a
|
family with sequence similarity 193, member A |
chr5_-_52471534 | 1.88 |
ENSMUST00000059428.5
|
Ccdc149
|
coiled-coil domain containing 149 |
chr17_+_37046555 | 1.87 |
ENSMUST00000172789.1
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr17_-_25256274 | 1.87 |
ENSMUST00000182435.1
ENSMUST00000169109.2 ENSMUST00000182056.1 |
Baiap3
|
BAI1-associated protein 3 |
chr13_+_38151324 | 1.87 |
ENSMUST00000127906.1
|
Dsp
|
desmoplakin |
chr16_+_20733104 | 1.86 |
ENSMUST00000115423.1
ENSMUST00000007171.6 |
Chrd
|
chordin |
chr18_-_24709348 | 1.85 |
ENSMUST00000067987.1
|
Gm9955
|
predicted gene 9955 |
chr5_-_138994935 | 1.85 |
ENSMUST00000046901.7
ENSMUST00000076095.7 |
Pdgfa
|
platelet derived growth factor, alpha |
chr4_+_54947976 | 1.84 |
ENSMUST00000098070.3
|
Zfp462
|
zinc finger protein 462 |
chr11_-_72135721 | 1.84 |
ENSMUST00000108508.2
ENSMUST00000075258.6 |
Pitpnm3
|
PITPNM family member 3 |
chr5_-_122050102 | 1.84 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr2_+_157914618 | 1.83 |
ENSMUST00000109523.1
|
Vstm2l
|
V-set and transmembrane domain containing 2-like |
chr13_-_92131494 | 1.82 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr4_-_140246751 | 1.82 |
ENSMUST00000039331.8
|
Igsf21
|
immunoglobulin superfamily, member 21 |
chr1_+_132880273 | 1.81 |
ENSMUST00000027706.3
|
Lrrn2
|
leucine rich repeat protein 2, neuronal |
chr9_-_96889381 | 1.81 |
ENSMUST00000112951.2
ENSMUST00000126411.1 ENSMUST00000078478.1 ENSMUST00000119141.1 ENSMUST00000120101.1 |
Acpl2
|
acid phosphatase-like 2 |
chr11_-_69122589 | 1.81 |
ENSMUST00000180487.1
|
9130213A22Rik
|
RIKEN cDNA 9130213A22 gene |
chr7_+_81213567 | 1.81 |
ENSMUST00000026672.7
|
Pde8a
|
phosphodiesterase 8A |
chr5_+_125003440 | 1.80 |
ENSMUST00000036109.3
|
Fam101a
|
family with sequence similarity 101, member A |
chr5_+_108694222 | 1.79 |
ENSMUST00000013633.8
ENSMUST00000112560.3 |
Fgfrl1
|
fibroblast growth factor receptor-like 1 |
chr3_+_114904062 | 1.78 |
ENSMUST00000081752.6
|
Olfm3
|
olfactomedin 3 |
chr8_+_127064022 | 1.77 |
ENSMUST00000160272.1
ENSMUST00000079777.5 ENSMUST00000162907.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr1_+_36511867 | 1.76 |
ENSMUST00000001166.7
ENSMUST00000097776.3 |
Cnnm3
|
cyclin M3 |
chr12_+_71016658 | 1.76 |
ENSMUST00000125125.1
|
Arid4a
|
AT rich interactive domain 4A (RBP1-like) |
chr19_+_3851797 | 1.75 |
ENSMUST00000072055.6
|
Chka
|
choline kinase alpha |
chr7_+_117380937 | 1.75 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr17_+_24752980 | 1.74 |
ENSMUST00000044922.6
|
Hs3st6
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
chr9_+_13246982 | 1.74 |
ENSMUST00000110583.2
ENSMUST00000169961.1 |
Ccdc82
|
coiled-coil domain containing 82 |
chr8_+_127064107 | 1.72 |
ENSMUST00000162536.1
ENSMUST00000026921.6 ENSMUST00000162665.1 ENSMUST00000160766.1 ENSMUST00000162602.1 ENSMUST00000162531.1 ENSMUST00000160581.1 ENSMUST00000161355.1 ENSMUST00000159537.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr5_+_36484578 | 1.72 |
ENSMUST00000060100.1
|
Ccdc96
|
coiled-coil domain containing 96 |
chr7_+_113207465 | 1.72 |
ENSMUST00000047321.7
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr15_+_89499598 | 1.71 |
ENSMUST00000109309.1
|
Shank3
|
SH3/ankyrin domain gene 3 |
chr17_-_87282771 | 1.71 |
ENSMUST00000161759.1
|
4833418N02Rik
|
RIKEN cDNA 4833418N02 gene |
chr17_+_24696234 | 1.70 |
ENSMUST00000019464.7
|
Noxo1
|
NADPH oxidase organizer 1 |
chr11_+_104132841 | 1.70 |
ENSMUST00000093925.4
|
Crhr1
|
corticotropin releasing hormone receptor 1 |
chr7_-_27396542 | 1.69 |
ENSMUST00000108363.1
|
Sptbn4
|
spectrin beta, non-erythrocytic 4 |
chr19_+_6341121 | 1.69 |
ENSMUST00000025897.6
ENSMUST00000130382.1 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr16_+_81200697 | 1.69 |
ENSMUST00000067602.3
ENSMUST00000037785.7 |
Ncam2
|
neural cell adhesion molecule 2 |
chr9_+_107399858 | 1.68 |
ENSMUST00000085092.5
ENSMUST00000164988.2 |
Cacna2d2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
chr15_+_89059712 | 1.67 |
ENSMUST00000161372.1
ENSMUST00000162424.1 |
Panx2
|
pannexin 2 |
chrX_-_162888426 | 1.66 |
ENSMUST00000033723.3
|
Syap1
|
synapse associated protein 1 |
chr11_+_69765970 | 1.66 |
ENSMUST00000108642.1
ENSMUST00000156932.1 |
Zbtb4
|
zinc finger and BTB domain containing 4 |
chr1_-_9967932 | 1.66 |
ENSMUST00000185184.1
|
Tcf24
|
transcription factor 24 |
chr12_+_112678803 | 1.66 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr5_-_5380185 | 1.66 |
ENSMUST00000030763.6
|
Cdk14
|
cyclin-dependent kinase 14 |
chr7_-_30445508 | 1.65 |
ENSMUST00000006828.7
|
Aplp1
|
amyloid beta (A4) precursor-like protein 1 |
chr17_-_25433775 | 1.65 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr2_+_27677234 | 1.65 |
ENSMUST00000166775.1
|
Rxra
|
retinoid X receptor alpha |
chr7_-_19796789 | 1.64 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr15_-_32244632 | 1.64 |
ENSMUST00000181536.1
|
0610007N19Rik
|
RIKEN cDNA 0610007N19 |
chr8_-_113848615 | 1.63 |
ENSMUST00000093113.4
|
Adamts18
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18 |
chr8_-_90908415 | 1.63 |
ENSMUST00000098517.1
|
Gm6658
|
predicted gene 6658 |
chr18_+_82692929 | 1.63 |
ENSMUST00000181931.1
|
Gm10524
|
predicted gene 10524 |
chr13_-_38151792 | 1.63 |
ENSMUST00000078232.1
|
Gm10129
|
predicted gene 10129 |
chr8_-_90348126 | 1.63 |
ENSMUST00000176034.1
ENSMUST00000176616.1 |
Tox3
|
TOX high mobility group box family member 3 |
chr8_+_4325205 | 1.60 |
ENSMUST00000069762.9
ENSMUST00000098949.4 ENSMUST00000127460.1 ENSMUST00000136191.1 |
Ccl25
Ccl25
|
chemokine (C-C motif) ligand 25 chemokine (C-C motif) ligand 25 |
chr13_+_38151343 | 1.59 |
ENSMUST00000124830.1
|
Dsp
|
desmoplakin |
chr4_-_43046196 | 1.59 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr8_+_54077532 | 1.59 |
ENSMUST00000033919.4
|
Vegfc
|
vascular endothelial growth factor C |
chr12_-_24096968 | 1.58 |
ENSMUST00000101538.3
|
9030624G23Rik
|
RIKEN cDNA 9030624G23 gene |
chr6_-_13838432 | 1.58 |
ENSMUST00000115492.1
|
Gpr85
|
G protein-coupled receptor 85 |
chr9_+_72925622 | 1.58 |
ENSMUST00000038489.5
|
Pygo1
|
pygopus 1 |
chr9_+_46012810 | 1.58 |
ENSMUST00000126865.1
|
Sik3
|
SIK family kinase 3 |
chr11_+_114851814 | 1.58 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr7_+_121865070 | 1.56 |
ENSMUST00000033161.5
|
Scnn1b
|
sodium channel, nonvoltage-gated 1 beta |
chr4_-_126533472 | 1.55 |
ENSMUST00000084289.4
|
Ago4
|
argonaute RISC catalytic subunit 4 |
chrX_+_170009892 | 1.55 |
ENSMUST00000180251.1
|
Gm21887
|
predicted gene, 21887 |
chr7_-_134938264 | 1.55 |
ENSMUST00000171394.1
|
Fam196a
|
family with sequence similarity 196, member A |
chr1_+_120340569 | 1.54 |
ENSMUST00000037286.8
|
C1ql2
|
complement component 1, q subcomponent-like 2 |
chr15_-_79804717 | 1.54 |
ENSMUST00000023057.8
|
Nptxr
|
neuronal pentraxin receptor |
chr6_-_148444336 | 1.54 |
ENSMUST00000060095.8
ENSMUST00000100772.3 |
Tmtc1
|
transmembrane and tetratricopeptide repeat containing 1 |
chr9_+_100643605 | 1.54 |
ENSMUST00000041418.6
|
Stag1
|
stromal antigen 1 |
chr1_+_43092588 | 1.53 |
ENSMUST00000039080.3
|
8430432A02Rik
|
RIKEN cDNA 8430432A02 gene |
chr17_-_64331817 | 1.53 |
ENSMUST00000172733.1
ENSMUST00000172818.1 |
Pja2
|
praja 2, RING-H2 motif containing |
chr5_+_110879788 | 1.53 |
ENSMUST00000156290.2
ENSMUST00000040111.9 |
Ttc28
|
tetratricopeptide repeat domain 28 |
chr13_+_31625802 | 1.53 |
ENSMUST00000042054.2
|
Foxf2
|
forkhead box F2 |
chr7_-_46179929 | 1.52 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr16_-_20621255 | 1.52 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr17_+_26113286 | 1.52 |
ENSMUST00000025010.7
|
Tmem8
|
transmembrane protein 8 (five membrane-spanning domains) |
chr19_+_5425121 | 1.52 |
ENSMUST00000159759.1
|
AI837181
|
expressed sequence AI837181 |
chr11_+_80300866 | 1.52 |
ENSMUST00000017836.7
|
Rhbdl3
|
rhomboid, veinlet-like 3 (Drosophila) |
chrX_+_142681398 | 1.50 |
ENSMUST00000112889.1
ENSMUST00000101198.2 ENSMUST00000112891.1 ENSMUST00000087333.2 |
Tmem164
|
transmembrane protein 164 |
chr7_-_34133215 | 1.50 |
ENSMUST00000038537.8
|
Wtip
|
WT1-interacting protein |
chrX_-_70365052 | 1.50 |
ENSMUST00000101509.2
|
Ids
|
iduronate 2-sulfatase |
chr2_+_19445632 | 1.50 |
ENSMUST00000028068.2
|
Ptf1a
|
pancreas specific transcription factor, 1a |
chr2_-_173276144 | 1.50 |
ENSMUST00000139306.1
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1 |
chr19_+_38836561 | 1.49 |
ENSMUST00000037302.5
|
Tbc1d12
|
TBC1D12: TBC1 domain family, member 12 |
chr9_-_121759788 | 1.49 |
ENSMUST00000181325.1
|
E530011L22Rik
|
RIKEN cDNA E530011L22 gene |
chr3_+_96181151 | 1.49 |
ENSMUST00000035371.8
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr2_-_13793793 | 1.49 |
ENSMUST00000003509.8
|
St8sia6
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
chr9_+_109095427 | 1.48 |
ENSMUST00000072093.6
|
Plxnb1
|
plexin B1 |
chr4_-_59549243 | 1.48 |
ENSMUST00000173699.1
ENSMUST00000173884.1 ENSMUST00000102883.4 ENSMUST00000174586.1 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr4_-_129057957 | 1.47 |
ENSMUST00000149472.2
|
1700086P04Rik
|
RIKEN cDNA 1700086P04 gene |
chr10_+_70097102 | 1.47 |
ENSMUST00000147545.1
|
Ccdc6
|
coiled-coil domain containing 6 |
chr12_+_24651346 | 1.46 |
ENSMUST00000020982.5
|
Klf11
|
Kruppel-like factor 11 |
chr9_+_75410145 | 1.46 |
ENSMUST00000180533.1
ENSMUST00000180574.1 |
4933433G15Rik
|
RIKEN cDNA 4933433G15 gene |
chr1_-_172206684 | 1.45 |
ENSMUST00000155109.1
|
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr1_-_84284423 | 1.45 |
ENSMUST00000176720.1
|
Pid1
|
phosphotyrosine interaction domain containing 1 |
chr9_-_20728219 | 1.44 |
ENSMUST00000034692.7
|
Olfm2
|
olfactomedin 2 |
chr11_+_117654798 | 1.44 |
ENSMUST00000106344.1
|
Tnrc6c
|
trinucleotide repeat containing 6C |
chr7_+_19094594 | 1.43 |
ENSMUST00000049454.5
|
Six5
|
sine oculis-related homeobox 5 |
chr8_-_11008458 | 1.43 |
ENSMUST00000040514.6
|
Irs2
|
insulin receptor substrate 2 |
chr5_-_143732273 | 1.43 |
ENSMUST00000053287.5
|
Usp42
|
ubiquitin specific peptidase 42 |
chr16_+_44173271 | 1.43 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr2_+_78869009 | 1.42 |
ENSMUST00000028398.7
|
Ube2e3
|
ubiquitin-conjugating enzyme E2E 3 |
chr2_+_103970221 | 1.41 |
ENSMUST00000111140.2
ENSMUST00000111139.2 |
Lmo2
|
LIM domain only 2 |
chr5_-_136567242 | 1.41 |
ENSMUST00000175975.2
ENSMUST00000176216.2 ENSMUST00000176745.1 |
Cux1
|
cut-like homeobox 1 |
chr17_+_69969073 | 1.40 |
ENSMUST00000133983.1
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr16_-_67620805 | 1.39 |
ENSMUST00000120594.1
|
Cadm2
|
cell adhesion molecule 2 |
chr5_-_67427794 | 1.38 |
ENSMUST00000169190.1
|
Bend4
|
BEN domain containing 4 |
chr4_-_129248431 | 1.38 |
ENSMUST00000052602.5
|
C77080
|
expressed sequence C77080 |
chr15_-_55906917 | 1.38 |
ENSMUST00000039769.5
|
Sntb1
|
syntrophin, basic 1 |
chr2_+_180710117 | 1.38 |
ENSMUST00000029090.2
|
Gid8
|
GID complex subunit 8 homolog (S. cerevisiae) |
chr2_-_128967725 | 1.37 |
ENSMUST00000099385.2
|
Gm10762
|
predicted gene 10762 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.7 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
1.7 | 5.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
1.6 | 4.7 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.4 | 4.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.2 | 3.5 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.0 | 3.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.0 | 2.9 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
1.0 | 5.9 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 0.9 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.9 | 3.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.8 | 5.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 5.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 3.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 3.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 2.4 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.8 | 1.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.8 | 3.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 2.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.7 | 4.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.7 | 2.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.7 | 2.1 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.7 | 4.0 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 2.0 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.6 | 1.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 1.9 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.6 | 3.2 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.6 | 1.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.6 | 4.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 2.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 1.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 5.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.6 | 1.8 | GO:2000864 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.6 | 1.2 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.6 | 2.9 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 2.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.6 | 3.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 2.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.6 | 2.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.6 | 2.3 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.6 | 3.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.7 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.5 | 1.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 3.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 2.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 3.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 2.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 0.5 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 2.1 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.5 | 2.6 | GO:0045994 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.5 | 1.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.5 | 1.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.5 | 1.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.5 | 6.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.5 | 2.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 2.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 2.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 0.5 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.5 | 1.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.5 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 2.8 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.5 | 4.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 0.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.5 | 0.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.5 | 3.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.4 | 1.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 2.7 | GO:0071543 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 | 1.8 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.4 | 3.1 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 1.3 | GO:0015866 | ADP transport(GO:0015866) |
0.4 | 3.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.4 | 0.9 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 3.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
0.4 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.4 | 5.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.4 | 1.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 0.8 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.4 | 0.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 2.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 1.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 3.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 0.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.4 | 1.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.4 | 1.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 2.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 1.1 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.4 | 1.1 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.4 | 1.1 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.4 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 1.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 3.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 2.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.4 | 1.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 3.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.3 | 2.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 1.4 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.3 | 0.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 3.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 1.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.3 | 1.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 1.0 | GO:1900224 | zygotic specification of dorsal/ventral axis(GO:0007352) regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
0.3 | 2.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 0.3 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.3 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.7 | GO:0070384 | Harderian gland development(GO:0070384) |
0.3 | 2.0 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.3 | 1.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.0 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.3 | 1.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 1.0 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.3 | 1.0 | GO:1900135 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) positive regulation of renin secretion into blood stream(GO:1900135) |
0.3 | 1.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 1.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.9 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.3 | 1.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 1.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.3 | 0.9 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.3 | 2.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.9 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.3 | 1.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.9 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.3 | 0.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 3.0 | GO:0046959 | habituation(GO:0046959) |
0.3 | 1.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 0.9 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 2.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.3 | 0.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 3.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 3.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 2.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 0.8 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.3 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 0.8 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 1.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.3 | 1.7 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 2.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.4 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.3 | 0.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 2.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 1.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 8.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 1.8 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.3 | 0.5 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 0.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.8 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 1.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.3 | 0.3 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 2.3 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 1.5 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 5.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 0.5 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.3 | 3.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.0 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.2 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 2.0 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 3.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.7 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 1.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 3.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.5 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.2 | 1.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.2 | 0.7 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.2 | 0.7 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.2 | 0.2 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 1.7 | GO:0015675 | nickel cation transport(GO:0015675) |
0.2 | 1.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 1.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.2 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.2 | 1.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.2 | 1.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.2 | 1.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 0.9 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.2 | 2.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 1.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.9 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.2 | 1.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 1.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 1.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.2 | 1.3 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 0.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.4 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 1.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 2.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 1.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 0.6 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 0.6 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.2 | 0.6 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.2 | 0.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 | 0.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.8 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.2 | 1.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.6 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 1.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 0.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 2.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 7.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.6 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.2 | 1.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 1.9 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 1.0 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 0.4 | GO:0060066 | oviduct development(GO:0060066) |
0.2 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 1.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 1.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 2.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.7 | GO:0043102 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.2 | 0.6 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 1.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.9 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.9 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.2 | 1.6 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.2 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 0.2 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 2.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 2.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.2 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.2 | 0.5 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 | 1.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 0.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.2 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 1.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 2.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 1.5 | GO:0010744 | regulation of macrophage derived foam cell differentiation(GO:0010743) positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.2 | 1.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 0.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.2 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.2 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
0.2 | 1.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 0.5 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 1.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 4.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 2.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 2.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 2.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 1.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.6 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 0.3 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.2 | 0.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 2.6 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 2.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.5 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.2 | 0.6 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 0.5 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 1.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 4.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.9 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 1.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 2.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.2 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.2 | 0.5 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 0.3 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.2 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.3 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.2 | 0.2 | GO:1902276 | amylase secretion(GO:0036394) pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
0.2 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.2 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 3.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 0.3 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.3 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.5 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 0.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.1 | 0.4 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.1 | 0.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 2.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 1.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.9 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 1.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.3 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 2.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 4.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.9 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.7 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) response to L-glutamate(GO:1902065) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.1 | 1.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 5.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.3 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 1.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 1.7 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.4 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.1 | 4.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.3 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.1 | 0.4 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.4 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.1 | 0.3 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 1.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 2.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.7 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 0.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 1.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 1.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.1 | 0.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.1 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 0.5 | GO:0060003 | copper ion export(GO:0060003) |
0.1 | 1.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.9 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.3 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 1.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 2.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
0.1 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.3 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 1.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.5 | GO:0003416 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 0.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 1.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.1 | 1.2 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.3 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 1.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.4 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) peptide antigen transport(GO:0046968) |
0.1 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.2 | GO:1904502 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.1 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.7 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 0.3 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 1.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) L-glutamate import across plasma membrane(GO:0098712) |
0.1 | 1.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.2 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.7 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 0.8 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.4 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 3.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.3 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.1 | 0.1 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 0.8 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 1.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 2.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 2.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.4 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.1 | 0.3 | GO:0017055 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 1.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.3 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 1.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.5 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.1 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 2.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 2.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
0.1 | 0.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 1.5 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.1 | 0.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.6 | GO:1902739 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0071338 | positive regulation of hair follicle cell proliferation(GO:0071338) |
0.1 | 0.3 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.1 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.5 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 1.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 1.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 0.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.1 | 0.1 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 2.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.7 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 1.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.5 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.2 | GO:1902683 | regulation of protein localization to synapse(GO:1902473) regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.5 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0002913 | positive regulation of T cell tolerance induction(GO:0002666) positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.1 | 0.2 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 1.2 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 1.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.2 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.5 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 2.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 1.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.3 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 1.7 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 4.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.1 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.6 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.1 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.4 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.6 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.3 | GO:0009744 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.2 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.1 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.2 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 3.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.1 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.4 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 1.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 | 0.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.1 | 0.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.4 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.1 | GO:0042660 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) positive regulation of cell fate specification(GO:0042660) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.2 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.6 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 1.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 1.1 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.4 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.1 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.2 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.3 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.2 | GO:0061620 | NADH regeneration(GO:0006735) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.2 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
0.1 | 0.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.1 | 1.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.0 | 0.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.1 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.0 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 2.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.1 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.0 | 0.0 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.0 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.0 | 0.4 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.0 | 0.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.3 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.1 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.0 | 0.0 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.0 | 1.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 1.0 | GO:0001707 | mesoderm formation(GO:0001707) |
0.0 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.1 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 1.0 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.0 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.0 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 1.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.0 | 0.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.3 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 1.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.0 | 0.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 1.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:1990743 | protein sialylation(GO:1990743) |
0.0 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 1.7 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 2.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 1.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.1 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.3 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.0 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.0 | 0.1 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.3 | GO:0061727 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 1.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.0 | 0.2 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0072716 | response to actinomycin D(GO:0072716) |
0.0 | 0.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.1 | GO:0002444 | myeloid leukocyte mediated immunity(GO:0002444) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.0 | 0.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.0 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 1.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.8 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.0 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.4 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 0.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.3 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.0 | 0.0 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.4 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.2 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.7 | 2.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.6 | 3.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 4.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.5 | 1.4 | GO:0098855 | HCN channel complex(GO:0098855) |
0.4 | 4.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 6.2 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 2.8 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 7.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 1.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.4 | 4.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 13.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 4.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.3 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 1.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 3.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 0.9 | GO:0036019 | endolysosome(GO:0036019) |
0.3 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 1.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 1.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 2.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 1.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 2.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 1.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 2.0 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 4.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 4.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.2 | 1.5 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 3.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.2 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 8.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.0 | GO:0031673 | H zone(GO:0031673) |
0.2 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 0.3 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.2 | 1.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 2.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0005610 | laminin-2 complex(GO:0005607) laminin-5 complex(GO:0005610) |
0.1 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 3.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 2.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.7 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.3 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.4 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 3.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 3.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.9 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 3.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.5 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.6 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.4 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 4.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 1.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.1 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 2.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 1.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 2.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 4.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.1 | 1.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 2.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 3.8 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 3.0 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 4.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 1.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 5.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 7.6 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.2 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.2 | GO:1990795 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.1 | 0.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 3.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 4.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 2.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 2.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 1.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 1.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 7.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 56.8 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 4.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 2.4 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 3.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 7.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 6.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 4.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.5 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 1.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 4.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 2.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.9 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 2.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 3.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 43.2 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.5 | 5.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.1 | 3.3 | GO:0035939 | microsatellite binding(GO:0035939) |
1.1 | 3.3 | GO:2001069 | glycogen binding(GO:2001069) |
1.0 | 4.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 2.9 | GO:0019002 | GMP binding(GO:0019002) |
1.0 | 2.9 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.9 | 2.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 2.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 2.6 | GO:0005118 | sevenless binding(GO:0005118) |
0.8 | 2.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 5.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 4.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.8 | 5.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.8 | 4.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 2.2 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.7 | 2.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.7 | 2.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.7 | 4.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 2.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 4.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 2.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.6 | 2.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 1.7 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.6 | 1.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.6 | 1.7 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.5 | 2.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 2.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.5 | 1.5 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.5 | 1.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.5 | 3.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 1.8 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.4 | 2.7 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.4 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.4 | 1.3 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.4 | 3.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.4 | 1.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.4 | 2.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 8.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 2.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 1.6 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 2.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 2.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.4 | 1.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.1 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.4 | 2.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 2.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 2.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 1.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 2.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 1.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 5.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.9 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 1.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 0.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.3 | 0.9 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.3 | 3.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.8 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.3 | 1.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 2.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 6.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 0.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.3 | 1.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.3 | 2.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 0.8 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 3.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 5.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 3.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 1.0 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 2.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.7 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.2 | 0.9 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.2 | 1.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 1.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 3.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 3.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 3.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 10.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.6 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 5.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.8 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.2 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 2.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 2.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 3.2 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 3.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 0.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 4.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 8.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 1.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 4.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.2 | 1.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 3.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.3 | GO:0070976 | TIR domain binding(GO:0070976) |
0.2 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.2 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.6 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.1 | 3.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.7 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 1.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 2.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 1.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 10.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 3.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 4.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 2.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 2.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.5 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.1 | 1.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 5.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.1 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 4.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 1.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 4.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.1 | 0.3 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.1 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.1 | GO:0030977 | taurine binding(GO:0030977) |
0.1 | 0.5 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.3 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 3.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 5.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 1.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 2.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 2.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.3 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.1 | 0.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.3 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 1.7 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 4.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.6 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.1 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 4.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.4 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 4.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 2.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.3 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 2.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 8.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.8 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.2 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 0.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.5 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 2.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0015389 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.0 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 2.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 2.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 1.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 2.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 1.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 1.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.0 | 0.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.2 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 1.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 1.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 2.1 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 2.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.0 | 0.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 1.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.7 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 0.4 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 0.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 10.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.0 | 0.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 1.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 4.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.5 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 0.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.0 | GO:0004335 | galactokinase activity(GO:0004335) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 4.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 5.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 3.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 9.1 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 5.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 5.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 4.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 6.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 7.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 7.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 2.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 10.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 4.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 4.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 3.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 5.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 2.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 6.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 3.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 6.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 0.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 7.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 2.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 6.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 3.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 11.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 7.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 8.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 6.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 1.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 4.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 8.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 4.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 7.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 5.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 4.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 4.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 7.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.4 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 5.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 4.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 4.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 3.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 5.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 2.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 3.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 4.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 6.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 5.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 3.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 4.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 3.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 1.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 1.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 4.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.2 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 2.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |